DNA constructs for cancer diagnosis and therapy

JP7789355B2Active Publication Date: 2025-12-22CNCURE BIOTECH INC
View PDF 0 Cites -1 Cited by

Patent Information

Application Number
JP2021565714
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-05-11
Filing Date
2020-05-11
Publication Date
2025-12-22
Estimated Expiration
2040-05-11

Smart Images

  • Figure 0007789355000002
    Figure 0007789355000002
  • Figure 0007789355000003
    Figure 0007789355000003
  • Figure 0007789355000004
    Figure 0007789355000004
Patent Text Reader

Abstract

The present invention relates to a DNA construct and a bacterial strain into which a recombinant vector containing the DNA construct has been introduced. The DNA construct of the present invention balances the expression levels of genes operably linked downstream of a first promoter and a second promoter in a host bacterial strain or cell, thereby enabling simultaneous cancer treatment and diagnosis. Furthermore, since the DNA construct of the present invention is unable to express the anticancer protein and reporter protein in the absence of doxycycline, by controlling the presence or absence of doxycycline treatment, the anticancer protein can be expressed at an appropriate dose for cancer treatment, and the size of the cancer can be monitored in real time based on the expression level of the reporter protein.
Need to check novelty before this filing date? Find Prior Art